S&P 500   3,236.92 (-2.37%)
DOW   26,763.13 (-1.92%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
S&P 500   3,236.92 (-2.37%)
DOW   26,763.13 (-1.92%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
S&P 500   3,236.92 (-2.37%)
DOW   26,763.13 (-1.92%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
S&P 500   3,236.92 (-2.37%)
DOW   26,763.13 (-1.92%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
Log in
NASDAQ:RMTI

Rockwell Medical Stock Forecast, Price & News

$1.20
-0.48 (-28.57 %)
(As of 09/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.13
Now: $1.20
$1.31
50-Day Range
$1.17
MA: $1.45
$1.80
52-Week Range
$1.10
Now: $1.20
$3.85
Volume18.46 million shs
Average Volume1.20 million shs
Market Capitalization$84.36 million
P/E RatioN/A
Dividend YieldN/A
Beta1.3
Rockwell Medical, Inc. operates as a specialty pharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis. It is also developing an intravenous formulation of Triferic for use by hemodialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. Its target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1994 and is based in Wixom, Michigan.
Read More
Rockwell Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.91 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:RMTI
CUSIP77437410
Phone248-960-9009

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$61.30 million
Book Value$0.32 per share

Profitability

Net Income$-34,130,000.00

Miscellaneous

Employees269
Market Cap$84.36 million
Next Earnings Date11/9/2020 (Estimated)
OptionableOptionable
$1.20
-0.48 (-28.57 %)
(As of 09/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Rockwell Medical (NASDAQ:RMTI) Frequently Asked Questions

How has Rockwell Medical's stock price been impacted by COVID-19?

Rockwell Medical's stock was trading at $2.88 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, RMTI shares have decreased by 58.3% and is now trading at $1.20.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Rockwell Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Rockwell Medical
.

When is Rockwell Medical's next earnings date?

Rockwell Medical is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020.
View our earnings forecast for Rockwell Medical
.

How were Rockwell Medical's earnings last quarter?

Rockwell Medical Inc (NASDAQ:RMTI) announced its quarterly earnings data on Monday, August, 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.14) by $0.04. The company earned $15.90 million during the quarter, compared to analyst estimates of $15.80 million. Rockwell Medical had a negative net margin of 47.94% and a negative return on equity of 146.49%.
View Rockwell Medical's earnings history
.

What guidance has Rockwell Medical issued on next quarter's earnings?

Rockwell Medical updated its second quarter 2020 After-Hours earnings guidance on Monday, July, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $15.4-15.8 million, compared to the consensus revenue estimate of $13.51 million.

What price target have analysts set for RMTI?

2 equities research analysts have issued 12 month price targets for Rockwell Medical's shares. Their forecasts range from $6.00 to $9.00. On average, they expect Rockwell Medical's stock price to reach $7.50 in the next year. This suggests a possible upside of 525.0% from the stock's current price.
View analysts' price targets for Rockwell Medical
.

Who are some of Rockwell Medical's key competitors?

What other stocks do shareholders of Rockwell Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seattle Genetics (SGEN), Geron (GERN), Opko Health (OPK), Amarin (AMRN), Gilead Sciences (GILD), Heron Therapeutics (HRTX), ImmunoGen (IMGN) and Eyepoint Pharmaceuticals (EYPT).

Who are Rockwell Medical's key executives?

Rockwell Medical's management team includes the following people:
  • Mr. Stuart Paul, Pres, CEO & Director (Age 59)
  • Mr. Angus W. Smith, Chief Financial Officer (Age 36)
  • Dr. Ajay Gupta, Chief Scientific Officer & Member of Scientific Advisory Board (Age 61)
  • Mr. Michael DeYoung, VP of Operations
  • Mr. David J. Kull, Principal Accounting Officer, Sec. & Controller (Age 51)

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

Who are Rockwell Medical's major shareholders?

Rockwell Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Bank of New York Mellon Corp (0.36%), Nuveen Asset Management LLC (0.34%), SkyOak Wealth LLC (0.28%), Bridgeway Capital Management Inc. (0.26%), Charles Schwab Investment Management Inc. (0.23%) and California Public Employees Retirement System (0.20%). Company insiders that own Rockwell Medical stock include Angus W Smith, David S Richmond, Russell H Ellison and Stuart M Paul.
View institutional ownership trends for Rockwell Medical
.

Which institutional investors are selling Rockwell Medical stock?

RMTI stock was sold by a variety of institutional investors in the last quarter, including Bridgeway Capital Management Inc., SkyOak Wealth LLC, UBS Group AG, and Nuveen Asset Management LLC.
View insider buying and selling activity for Rockwell Medical
.

Which institutional investors are buying Rockwell Medical stock?

RMTI stock was acquired by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, OneAscent Financial Services LLC, Johnson Investment Counsel Inc., Bank of New York Mellon Corp, Sigma Investment Counselors Inc., Prudential Financial Inc., Bank of America Corp DE, and Charles Schwab Investment Management Inc.. Company insiders that have bought Rockwell Medical stock in the last two years include Angus W Smith, David S Richmond, Russell H Ellison, and Stuart M Paul.
View insider buying and selling activity for Rockwell Medical
.

How do I buy shares of Rockwell Medical?

Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Rockwell Medical's stock price today?

One share of RMTI stock can currently be purchased for approximately $1.20.

How big of a company is Rockwell Medical?

Rockwell Medical has a market capitalization of $84.36 million and generates $61.30 million in revenue each year. The company earns $-34,130,000.00 in net income (profit) each year or ($0.56) on an earnings per share basis. Rockwell Medical employs 269 workers across the globe.

What is Rockwell Medical's official website?

The official website for Rockwell Medical is www.rockwellmed.com.

How can I contact Rockwell Medical?

Rockwell Medical's mailing address is 411 HACKENSACK AVENUE SUITE 501, HACKENSACK NJ, 07601. The company can be reached via phone at 248-960-9009 or via email at [email protected]

This page was last updated on 9/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.